These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17455695)

  • 1. [Vaccines in Japan].
    Kato T
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():637-8. PubMed ID: 17455695
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese Childhood Vaccination Policy.
    Doshi P; Akabayashi A
    Camb Q Healthc Ethics; 2010 Jul; 19(3):283-9. PubMed ID: 20507675
    [No Abstract]   [Full Text] [Related]  

  • 3. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against communicable diseases.
    Krugman S; Perkins FT
    Am J Dis Child; 1973 Sep; 126(3):406-8. PubMed ID: 4746553
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on vaccine safety.
    Zimmerman RK; Kimmel SR; Trauth JM
    Am Fam Physician; 1996 Jul; 54(1):185-93. PubMed ID: 8677834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of the HIV-1 infected child.
    Madhi SA
    SADJ; 2001 Dec; 56(12):610-3. PubMed ID: 11887449
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization activities.
    Farrington PH
    J Ark Med Soc; 1973 Dec; 70(7):250-1. PubMed ID: 4272004
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
    Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
    Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine requirements of college students.
    Blake PA
    J Am Coll Health Assoc; 1972 Dec; 21(2):131-3. PubMed ID: 4641386
    [No Abstract]   [Full Text] [Related]  

  • 16. CURRENT CONCEPTS IN THERAPY ACTIVE IMMUNIZATIONS.
    TAUB JS; HAGGERTY RJ
    N Engl J Med; 1963 Sep; 269():573-6 CONCL. PubMed ID: 14043261
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan.
    Horiuchi Y; Takahashi M; Konda T; Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y
    Jpn J Infect Dis; 2001 Oct; 54(5):167-80. PubMed ID: 11754154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving child survival through immunisation.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revaccination of children after completion of standard chemotherapy for acute leukemia.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.